DUARTE, Calif.--(BUSINESS WIRE)--Internationally renowned biostatistician and epidemiologist Leslie Bernstein, Ph.D., professor in the Division of Biomarkers of Early Detection and Prevention, Department of Population Sciences at City of Hope, has been selected to receive the American Association for Cancer Research’s (AACR) 27th Annual American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention for her outstanding research accomplishments in the fields of cancer epidemiology, biomarkers and prevention.
Bernstein, an award-winning pioneer in breast cancer research spanning nearly 40 years, has led numerous groundbreaking research studies on breast and other cancers, hormones and reproductive endocrinology. She garnered global recognition for her groundbreaking research study, published in 1994, which identified the link between physical activity and the reduced risk of breast cancer. That same year, she also helped launch the California Teachers Study, a more than two decades-long seminal breast cancer study of more than 133,000 public school professionals.
Recently, Bernstein published results showing that the use of low-dose aspirin (81mg) reduces the risk of breast cancer in women who are part of the California’s Teacher’s Study. This study is the first to suggest that the reduction in risk occurs for low-dose aspirin.
Bernstein is only the third woman to receive this AACR honor. She was nominated by AACR’s Molecular Epidemiology Working Group and will be presented with the award at the AACR annual conference on April 16, 2018, in Chicago. She will also give a presentation titled, “Evolving approaches in cancer epidemiology: Time, serendipity, and risk.”
“Receiving an award from AACR is one of the highest honors for someone in my field,” Bernstein said. “AACR is the largest scientific organization in the world that understands and advances high-quality, innovative cancer research. I am extremely humbled to receive this top honor.”
Bernstein was also honored by AACR in 2007 with the organization’s Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research, which recognizes her seminal contributions to the field of cancer prevention research in basic, translational, clinical, epidemiological and behavioral science.
“Over her decades-long career, Dr. Bernstein’s work as a biostatistician and cancer epidemiologist has transformed the way researchers, clinicians and others perceive the ability to modify cancer risk,” said Michael Caligiuri, M.D., president of City of Hope National Medical Center and the Deana and Steve Campbell Physician-in-Chief Distinguished Chair. “Her research has shown how hormones, environmental chemicals, diet and obesity can alter breast cancer risk. Bernstein’s greatest contributions have been to our understanding of the impact of physical activity: Her studies clearly established that exercise over the course of a lifetime can reduce an individual’s cancer risk, and that physical activity can affect disease prognosis and quality of life in survivors.”
As the former director of City of Hope’s Division of Cancer Etiology and dean of faculty affairs, Bernstein has received numerous awards and honors for her distinguished work in research and mentorship. As a highly regarded mentor to students, postdoctoral fellows and junior faculty, Bernstein has been recognized with City of Hope’s Lifetime Achievement Mentoring Award in recognition of her commitment to mentorship. Among her many other awards, she was the recipient of the Brinker Award for Scientific Distinction at the San Antonio Breast Cancer Symposium, received the ninth Rosalind E. Franklin Award for Women in Science given by the National Cancer Institute, a subgroup of National Institutes of Health, and was the recipient of the Abraham Lilienfeld Award for Lifetime Contributions to Epidemiology given by the American College of Epidemiology.
About City of Hope
City of Hope is an independent research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as one of only 49 comprehensive cancer centers, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the world. City of Hope is located in Duarte, California, just northeast of Los Angeles, with community practice sites throughout Southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation, diabetes and numerous breakthrough cancer drugs based on technology developed at the institution. For more information about City of Hope, follow us on Facebook, Twitter, YouTube or Instagram.